BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Zhipeng Cao, Yuqing Jia, Baoli Zhu · International Journal of Molecular Sciences · 2019 · Review
Full textCC BY
Medicine: papers
Filters2 filters applied
Status
- Corrected
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Dongfeng Gu, Jiang He, Pamela G Coxson et al. · PLoS Medicine · 2015
Abstract onlyNot checked
Natural selection and local adaptation of blood pressure regulation and their perspectives on precision medicine in hypertension
Boon-Peng Hoh, Thuhairah Abdul Rahman, Khalid Yusoff · Hereditas · 2019
Abstract onlyNot checked
Application of pre-participation cardiovascular screening guidelines to novice older runners and endurance athletes
Justin R Abbatemarco, Courtney Bennett, Adrian J Bell et al. · SAGE Open Medicine · 2016
Abstract onlyNot checked
Possibilities of applying pharmacological stress testing in assessment of heart functional capacity in dogs
Kosić-Spasojević Ljubica, Trailović Dragiša R. · Veterinarski Glasnik · 2010
Abstract onlyNot checked
Quality of blood pressure control in hypertensive patients attending the Kigali University Teaching Hospital (CHUK)
P. Kamali, C. Page, A. Kagame · Annals of Global Health · 2016
Abstract onlyNot checked
Assessment of hypertension and its associated risk factors among medical students in Qassim University
Ahmed Humaidan AlWabel, Mohammed Ali Almufadhi, Faisal Mohammed Alayed et al. · Saudi Journal of Kidney Diseases and Transplantation · 2018
Abstract onlyNot checked
Comparison of a portable novel cardiovascular assessment device against echocardiographic assessment in a rural Bangladesh population
S.B. Feenstra, H. Ahsan · Annals of Global Health · 2014
Abstract onlyNot checked
Prehypertension and Hypertension in Bangladesh – Modifiable Lifestyle Factors
M. Rahman, Y. Fakir · Annals of Global Health · 2017
Abstract onlyNot checked
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Shayan Moazeni, Martin Cadeiras, Eric H. Yang et al. · Clinical and Translational Medicine · 2017
Abstract onlyNot checked
Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs
Rajeev Gupta, Salim Yusuf · BMC Medicine · 2019
Abstract onlyNot checked
A New Model to Perform Electrophysiological Studies in the Early Embryonic Mouse Heart
Anna Kornblum, Frank Pillekamp, Matthias Matzkies et al. · Cellular Physiology and Biochemistry · 2013
Abstract onlyNot checked
The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
Jiayu Wang, Jia Zhang, Yuan Shen et al. · BMC Cardiovascular Disorders · 2019
Abstract onlyNot checked
The complex interaction between atrial fibrillation and heart failure in elderly patients
Stefano Fumagalli, Giulia Pelagalli, Marta Migliorini et al. · Monaldi Archives for Chest Disease · 2019
Abstract onlyNot checked
The Draupadi of dyslipidemia: Familial hypercholesterolemia
Sanjay Kalra, JPS Sawhney, Rakesh Sahay · Indian Journal of Endocrinology and Metabolism · 2016
Abstract onlyNot checked
Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p
Haifeng Zhang, Shanshan Li, Qiulian Zhou et al. · Cellular Physiology and Biochemistry · 2016
Abstract onlyNot checked
Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models
Cecilia Ferrantini, Raffaele Coppini, Josè Manuel Pioner et al. · Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease · 2017
Abstract onlyNot checked
Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
Amit P. Amin, Samantha Miller, Brandon Rahn et al. · Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease · 2018
Abstract onlyNot checked
Confidence and performance of health workers in cardiovascular risk factor management in rural Botswana: a cross-sectional study
Pooja Gala, MD, Bhavna Seth, MD, Veronica Moshokgo, MBBS et al. · The Lancet Global Health · 2019
Abstract onlyNot checked
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
PILL Collaborative Group, Anthony Rodgers, Anushka Patel et al. · PLoS ONE · 2011
Abstract onlyNot checked